Role of medical history and medication use in the aetiology of upper aerodigestive tract cancers in Europe: The ARCAGE study

Annals of Oncology

Volumn 23, Issue 4, 2012, Pages 1053-1060

  Macfarlane, T V ^a   Macfarlane, G J ^a   Thakker, N S ^b   Benhamou, S ^c   Bouchardy, C ^d   Ahrens, W ^e   Pohlabeln, H ^e   Lagiou, P ^f   Lagiou, A ^f,g   Castellsague, X ^h   Agudo, A ^h   Slamova, A ⁱ   Plzak, J ^j   Merletti, F ^k   Richiardi, L ^k   Talamini, R ^l   Barzan, L ^m   Kjaerheim, K ⁿ   Canova, C ^o   Simonato, L ^p   Conway, D I ^q   Mckinney, P A ^r   Thomson, P ^s   Sloan, P ^s   Znaor, A ^t   Healy, C M ^u   McCartan, B E ^v   Marron, M ^w   Brennan, P ^x   more..

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d GENEVA CANCER REGISTRY   (Switzerland)

^e UNIVERSITY OF BREMEN   (Germany)

^f UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^g UNIVERSITY OF WEST ATTICA   (Greece)

^h CATALAN INSTITUTE OF ONCOLOGY   (Spain)

ⁱ CHARLES UNIVERSITY   (Czech Republic)

^j UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^k UNIVERSITY OF TURIN   (Italy)

^l CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^m S MARIA DEGLI ANGELI HOSPITAL   (Italy)

ⁿ CANCER REGISTRY OF NORWAY   (Norway)

^o IMPERIAL COLLEGE LONDON   (United Kingdom)

^p UNIVERSITY OF PADOVA   (Italy)

^q UNIVERSITY OF GLASGOW   (United Kingdom)

^r UNIVERSITY OF LEEDS   (United Kingdom)

^s NEWCASTLE UNIVERSITY   (United Kingdom)

^t Croatian National Bank   (Croatia)

^u DUBLIN DENTAL UNIVERSITY HOSPITAL   (Ireland)

^v ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^w UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^x INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

more..

Author keywords

Aspirin use; Epidemiology; Gastroesophageal reflux; Medical history; Medication use; Upper aerodigestive tract cancer

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; ARTICLE; CANCER RISK; CANDIDIASIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG USE; ESOPHAGUS CANCER; EUROPE; GASTROINTESTINAL REFLUX; GEOGRAPHIC DISTRIBUTION; HEARTBURN; HERPES SIMPLEX; HUMAN; HYPOPHARYNX CANCER; INFECTION RISK; INTERMETHOD COMPARISON; LARYNX CANCER; MAJOR CLINICAL STUDY; MEDICAL HISTORY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; VERRUCA VULGARIS;

EID: 84859483908     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr335     Document Type: Article

References (33)

1. Ferlay J, Shin HR, Bray F et al. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer 2010; http://globocan.iarc.fr (7 July 2011, date last accessed).
2. Garavello W, Bertuccio P, Levi F et al. The oral cancer epidemic in central and eastern Europe. Int J Cancer 2010; 127: 160-171.
3. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 83-Tobacco Smoke and Involuntary Smoking. Lyon, France: IARC-publisher 2004.
4. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 96. Alcohol Consumption and Ethyl Carbamate. Lyon, France: IARC-publisher 2010.
5. Lagiou P, Talamini R, Samoli E et al. Diet and upper-aerodigestive tract cancer in Europe: the ARCAGE study. Int J Cancer 2009; 124: 2671-2676.
6. Warnakulasuriya S. Causes of oral cancer-an appraisal of controversies. Br Dent J 2009; 207: 471-475.
7. Franceschi S, Muñoz N, Bosch XF et al. Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. Cancer Epidemiol Biomarkers Prev 1996; 5: 567-575.
8. Gillison ML, Koch WM, Capone RB et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-720.
9. D'Souza G, Kreimer AR, Viscidi R et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356: 1944-1956.
10. Rotnaglova E, Tachezy R, Salaková M et al. HPV involvement in tonsillar cancer: prognostic significance and clinically relevant markers. Int J Cancer 2011; 129: 101-110.
11. Mehanna H, Jones TM, Gregoire V, Ang KK. Oropharyngeal carcinoma related to human papillomavirus. BMJ 2010; 340: c1439
12. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467-475.
13. Thavaraj S, Stokes A, Guerra E et al. Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice. J Clin Pathol 2011; 64: 308-312; [Epub ahead of print 2011 February 23].
14. Kabat GC, Hebert JR, Wynder EL. Risk factors for oral cancer in women. Cancer Res 1989; 49: 2803-2806.
15. Krogh P. The role of yeasts in oral cancer by means of endogenous nitrosation. Acta Odontol Scand 1990; 48: 85-88.
16. Garrote FL, Herrero R, Reyes RM et al. Risk factors for cancer of the oral cavity and oro-pharynx in Cuba. Br J Cancer 2001; 85: 46-54.
17. Talamini R, Vaccarella S, Barbone F et al. Oral hygiene, dentition, sexual habits and risk of oral cancer. Br J Cancer 2000; 83: 1238-1242.
18. Duan L, Wu AH, Sullivan-Halley J, Bernstein L. Antacid drug use and risk of esophageal and gastric adenocarcinomas in Los Angeles County. Cancer Epidemiol Biomarkers Prev 2009; 18: 526-533.
19. Lagergren J, Bergström R, Lindgren A, Nyrénet O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-831.
20. Steele C, Shillitoe EJ. Viruses and oral cancer. Crit Rev Oral Biol Med 1991; 2: 153-175.
21. Maden C, Beckmann AM, Thomas DB et al. Human papillomaviruses, herpes simplex viruses, and the risk of oral cancer in men. Am J Epidemiol 1992; 135: 1093-1102.
22. Hooper SJ, Wilson MJ, Crean SJ. Exploring the link between microorganisms and oral cancer: a systematic review of the literature. Head Neck 2009; 31: 1228-1239.
23. Bosetti C, Gallus S, La Vecchia C. Aspirin and cancer risk: an updated quantitative review to 2005. Cancer Causes Control 2006; 17: 871-888.
24. Rothwell PM, Fowkes FG, Belch JF et al. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011; 377: 31-41.
25. Bosetti C, Talamini R, Franceschi S et al. Aspirin use and cancers of the upper aerodigestive tract. Br J Cancer 2003; 88: 672-674.
26. Rosenquist K, Wennerberg J, Schildt EB et al. Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden. Acta Otolaryngol 2005; 125: 1327-1336.
27. Friis S, Poulsen A, Pedersen L et al. Use of nonsteroidal anti-inflammatory drugs and risk of oral cancer: a cohort study. Br J Cancer 2006; 95: 363-365.
28. Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 2002; 94: 252-266.
29. Lagiou P, Georgila C, Minaki P et al. Alcohol-related cancers and genetic susceptibility in Europe: the ARCAGE project: study samples and data collection. Eur J Cancer Prev 2009; 18: 76-84.
30. StataCorp. 2009. Stata Statistical Software: Release 11. College Station, TX: StataCorp LP.
31. Winn DM, Blot WJ, McLaughlin JK et al. Mouthwash use and oral conditions in the risk of oral and pharyngeal cancer. Cancer Res 1991; 51: 3044-3047.
32. Shillitoe EJ, Silverman S Jr. Oral cancer and herpes simplex virus-a review. Oral Surg Oral Med Oral Pathol 1979; 48: 216-224.
33. Conway DI, Hashibe M, Boffetta P. Enhancing epidemiologic research on head and neck cancer: INHANCE-The international head and neck cancer epidemiology consortium. Oral Oncol 2009; 45: 743-746.